WHO ICTRP trial
Effect of combined hypertonic therapy on cerebral reperfusion edema after…
ChiCTR2400089582 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400089582 |
|---|---|
| Public title | Effect of combined hypertonic therapy on cerebral reperfusion edema after intravascular thrombectomy in ischemic stroke: a multicenter, prospective, randomized, open-label, endpoint blind study |
| Scientific title | Effect of combined hypertonic therapy on cerebral reperfusion edema after intravascular thrombectomy in ischemic stroke: a multicenter, prospective, randomized, open-label, endpoint blind study - CHEAMT Study |
| Primary sponsor | The First Hospital of Yulin |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | 320-320.54;320-320.54 |
| Interventions | experimental group:The experimental group was given continuous drops of 3% hypertonic saline immediately after surgery, and the target monitoring blood sodium concentration was maintained at 150-160mol/L, and 20g of albumin was given, 1/… |
| Registration date | Sep 11, 2024 |
| Target size | experimental group:47;control group:47 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: